premier site for EMS responders,  instructors and students 
~ all with a dash of fun~

EMS House  of DeFrance

the human face of EMS cyberspace


A mind once stretched by a new idea never regains its original dimensions

 

Email this article  | Printer friendly page    

  Peripheral Med


 Hope rekindled for blood substitute
by

Hopes that a blood substitute being tested at Mayo Clinic and other medical centers would turn into a life-saving alternative were nearly dashed earlier this year, but those hopes have been revived. 


Northfield Laboratories, the company behind the blood substitute called Polyheme (made from chemically altered hemoglobin taken from expired units of donated blood), says mistakes in its study misclassified many study participants, so the results were not as poor as they seemed.

Dr. Andy Boggust, a site investigator for the study at Saint Marys Hospital in Rochester, said errors skewed the results. Some participants were marked as Polyheme recipients when they didn't receive it. Deaths in that group were incorrectly marked as Polyheme deaths.

"There were a lot of problems with entry into the study," Boggust said. That's actually why he thinks Polyheme looks good in the end.

After protocol violations were removed, Boggust said, only patients treated as the protocol required remained. They were called the "per-protocol" group.

Those patients did just as well as standard-therapy patients, Boggust said, leading him to favor Food and Drug Administration approval of Polyheme.

"When blood is not available for a patient, I think this is a very acceptible alternative," he said.

The product would be most useful during ambulance and air-ambulance transport, Boggust said, when the oxygen-carrying capacity of blood is needed but no blood is available.

The study

The study in question looked at 714 trauma patients nationwide who used either Polyheme or standard therapy of IV fluids. About 20 study participants with life-threatening traumatic injuries were treated at Saint Marys.

They randomly received either Polyheme or standard therapy from ambulance crews.

Widely reported study results showed disappointing results for Northfield Laboratories in May.

The study showed 13.2 percent of patients who received Polyheme died.

Deaths weren't unexpected; severely traumatized patients often die.

The FDA granted Northfield a waiver to rules that normally require informed consent before a patient can be entered in a study. That became controversial during the final days of study enrollment, but all patient slots were filled shortly thereafter.

What was unexpected? Only 9.6 percent of study participants who received standard therapy died.

In other words, if you received standard thereapy of saline solution, you were more likely to survive -- or so it seemed.

What's next?

Northfield Laboratories plans to submit a biologic license agreement to the FDA on Oct. 27. If approved, the license would allow Northfield to begin market preparations for use of the product for trauma patients.

Northfield chief executive officer Steven Gould told stockholders that an article about the study is scheduled for publication in the Journal of the American College of Surgeons online as early as November. He said Polyheme's benefits include universal compatibility with all blood types, long-term storage ability and a reduced risk of viral disease.

"I think we've certainly met the endpoints and that this is a product that fills a critically unmet need," Boggust said.

Not everyone believes the product is ready for primetime, though.

Dr. Gregory Vercellotti, professor of medicine in the division of hematology, oncology and transplantation at the University of Minnesota, said he has watched the field of blood substitutes closely -- and he would not use Polyheme.

Vercellotti cites a 2008 Journal of the American Medical Association study that he says looked at all blood-substitute studies, including Polyheme studies, and found increased risk of death and heart attack among patients.

Vercellotti said he believes an oxygen-carrying blood substitute is needed, but he doesn't think Polyheme is necessarily it.

"The real question is does it save lives? And does it save morbidity? Which is another question beyond safety, and I'm just not sure I have seen that," he said.

 

 

Oct 18, 2008
source/photo courtesy of



Top of Page

THE EMS STORE
sales support this site
Latest in  Peripheral Med
more > see category page bottom
Lab-made organ implanted for first time
Gallery: Military’s Freakiest Medical Projects
Link Between Diabetes, Alzheimer's Disease Strengthened
Cardiac device AngelMed Guardian gets test run at Salinas Valley Memorial Hospital
Transparency: How You Will Get Hurt at Burning Man
Study Says Brain Trauma Can Mimic Lou Gehrig’s Disease
First Batch of DARPA's Synthetic Blood Delivered to FDA, Could Be on Battlefields Soon
AHA Scientific Statement: Management of Cocaine-Associated Chest Pain and Myocardial Infarction
Tracheostomy Tubes Recalled After 3 Deaths
Device zaps airways to help asthmatics breathe
Erectile dysfunction a red flag for mortality, cardiovascular events
A must listen 911 call
Paramedic's invention clears throats of stroke, heart-attack victims
ACLS: Close the Drug Box
Johns Hopkins study says shooting/stabbing patients twice as likely to die if immobilized before transport
Introducing the bra that is meant to be taken off
The Bloodbot Project
Device safely removes Taser darts
Video of Live RPG removed from soldier - Afghanistan
Tattoo medical alerts raising eyebrows
Triage technology with a Star Trek twist
Man's head is speared
Should ABC be CBA in treating wounded officers? An important clarification
Endless, Pure New Blood From Stem Cells?
Ambulance Stethoscopes May Carry Deadly Bacteria, New Research Finds
Saving lives in a virtual world
Hope rekindled for blood substitute
Wound treatment device tested on flights
Blood Substitute Found Safe in Large Phase III Trial
Filling the Blood Gap with a Substitute
Medical ID Bracelets Made Fashionable; Even Halle Berry Wears One
Medical community warming up to freeze therapy
Post potential pathogenic exposure germ-killing spray hits market
Agents warn of new drug hitting U.S.
Top Product Innovations for 2007
CPR and Shock Simultaneously Aids Resuscitation, Safe for Workers
FDA Approval for FlexWarmer
Back From the Dead
Noninvasive Pneumothorax Detector
New Drug-Dispensing Gun Saves Lives
PPH - Heart Failure or Just Plain Weakness?
Enzyme Discovery Could Greatly Expand Blood Supply
THE Glove
Medicine races to keep up with street weaponry
Use of Caffeine Supplements Getting Dangerous
Promising new liquid seals off wounds in just seconds
First fully mine-protected battle ambulance
Wake County NC paramedics use new 'cool aid' method
Have you used this?
The Battle Against Bleeding
for additional items, see the page bottom of each category

AK Fun and Ninja EMT shirts at the EMS Store
Personalized orders accepted,
send  to a friend- gift card included.



Baseball Jersey
Blue, Black or Red

The contents of this site, unless otherwise specified, are copyright by © EMS House of DeFrance.

Disclaimer: The information presented herein is not necessarily endorsed by the EMS House of DeFrance or any of its branches or sub sites. Users are reminded to consult with local controls before adopting procedures described in any information presented on this site, or any of its branches or sub sites. 

© EMS House of DeFrance. All Rights Reserved. Unauthorized reproduction or commercial use of these materials prohibited without prior written consent of the EMS House of  DeFrance and/or the author. The name EMS House of  DeFrance and associated EMS House of  DeFrance logo(s) are trademarks of EMS House of  DeFrance. Contact:
defrance@defrance.org